Zevra Therapeutics, Inc. (ZVRA)
9.23
-0.17
(-1.81%)
USD |
NASDAQ |
Mar 20, 16:00
9.24
+0.01
(+0.11%)
After-Hours: 20:00
Zevra Therapeutics Research and Development Expense (Quarterly) : 2.574M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Stereotaxis, Inc. | 2.71M |
| Ironwood Pharmaceuticals, Inc. | 21.40M |
| Verastem, Inc. | 31.68M |
| ADMA Biologics, Inc. | 1.376M |
| Myomo, Inc. | 1.625M |